PTU - Polskie Towarzystwo Urologiczne
list of articles:

Combined treatment of patient with germ cell tumour of the testis and metastases in retroperitoneal space, lungs and brain leading to complete remission
Article published in Urologia Polska 2002/55/3.


Małgorzata Sadowska, Tomasz Demkow, Iwona Skoneczna, Marek Szczerbicki
Centrum Onkologii — Instytut im. Marii Skłodowskiej-Curie w Warszawie
Klinika Nowotworów Układu Moczowego
Kierownik kliniki: dr hab. Tomasz Demkow


testis, testicular cancer, combined treatment, poor prognosis group


The case of a patient with nonseminomatous germ cell tumour of the left testis with metastatic lesions in brain, lung and retroperitoneal space has been presented. The patient achieved complete remission (CR) with combined treatment consisted of intensive chemotherapy and surgery: craniotomy with metastascctomy and removal of residual masses from thorax and retroperitoneal space. There is no evidence of disease in the patient in the moment of publication, 24 months after completion of the therapy.


  1. 1. International Germ Cell Cancer Collaborative Group: International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997; 15:594-602.
  2. 2. Madej G: Chemioterapia nowotworów układu moczowo-płciowego; w Madej G; Chemioterapia Onkologiczna Dorosłych i Dzieci, Warszawa PZWL 1999; 372-374.
  3. 3. Hendry WF, Goldstraw P et al: The role of surgery in the combined management of metastases from testicular teratomas of testis. Br J Urol,1987;59:358.
  4. 4. Bokemeyer C, Schmoll HJ, Harstrick A et al: A phase I/II study of a stepwise dose-escalated regimen ofcisplatin, etopo-side and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours. Eur. J Cancer 1993; 29A:2225-2231.
  5. 5. Chevreau C, Pico JL, Kervrat P et al: Early intensified chemotherapy with autologous bone marrow transplatation in first line treatment of poor risk non-seminomatous germ cell tumours. Eur Urol 1993; 23: 213-218.
  6. 6. Kaiser GH, Paluchowska B, Fossa SD, Horwich A, De Mulder PHM, De Prijck L, Collette L et EORTC genito-urinary tract cancer cooperative group: An EORTC phase II trial ofC-BOP/BEP intensive induction chemotherapy for intermediate and poor risk metastatic germ cell tumours. Eur Urol 2000; 37 (Suppl. 2): 88 (abs. 352).
  7. 7. Motzer RJ, Mazumdar M, Gulati SC et al: Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. J Nat Cancer Inst, 1993; 85:1828-1835.
  8. 8. Baniel J, Foster RS, Gonin R, Messemer JE, Donohue JP, Einhorn LH:Late relapse of testicular cancer. J Clin Oncol 1995; 13:1170-1176
  9. 9. Borge N, Fossa SD, Ous S, Stenwig AE, Lien HH: Late recurrence of testicular cancer. J Clin Oncol 1988; 6:1248-1253.


Małgorzata Sadowska
Centrum Onkologii - instytut im. Marii Sktodowskiej-Curie
Klinika Nowotworów Układu Moczowego
ul. W. K. Roentgena 5
02-781 Warszawa
tel/fax: (0-22) 643 92 31